Who has invested in FerGene?

Ferring Pharmaceuticals, Blackstone Life Sciences are named among the investors backing FerGene.

FerGene Funding: $570M Raised, Investors & Rounds

FerGene funding overview

FerGene is based in Cambridge. FerGene has raised $570M in total disclosed funding. That places its disclosed total in the $250M–$1B range. The round record for FerGene runs through 2019; nothing later has been disclosed. Investors on record include Ferring Pharmaceuticals, Blackstone Life Sciences. 2 distinct backers are named across the disclosed rounds.

FerGene at a glance

Total raised: $570M
Latest round date: November 2019
Headquarters: Cambridge
Notable investors: Ferring Pharmaceuticals, Blackstone Life Sciences

Frequently asked about FerGene funding

How much has FerGene raised?: FerGene has raised $570M in total disclosed funding across the rounds on record.
Who has invested in FerGene?: Ferring Pharmaceuticals, Blackstone Life Sciences are named among the investors backing FerGene.
What was the latest FerGene funding round?: No round stage has been disclosed for FerGene.
Where is FerGene based?: FerGene is based in Cambridge.
When did FerGene last raise?: The last disclosed FerGene round closed in November 2019.

Round data for FerGene is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

FerGene Funding: $570M Raised, Investors & Rounds

FerGene funding overview

FerGene at a glance

Frequently asked about FerGene funding

Companies related to FerGene (18)

Browse related funding lists (4)